Key facts
- Laura Natalia Monica Fonda filed SCHEDULE 13G for OKYO Pharma Ltd Common (OKYO).
- Disclosed ownership: 5%.
- Date of event: 22 Jul 2025.
Laura Natalia Monica Fonda - 22 Jul 2025 SCHEDULE 13G Report for OKYO Pharma Ltd Common (OKYO)
- Filing Manager
- Laura Natalia Monica Fonda
- Reporting Manager
- LAURA NATALIA MONICA FONDA
- Security
- OKYO Pharma Ltd Common
- Symbol
- OKYO
- Shares outstanding
- 38,492,036 shares
- Disclosed Ownership
- 1,928,451 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 29 Oct 2025, 08:30:01 UTC
- Date of event
- 22 Jul 2025
- SEC
- View on sec.gov
Key filing fact
Laura Natalia Monica Fonda disclosed 5% ownership in OKYO Pharma Ltd Common (OKYO) on 22 Jul 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Oct 2025, 08:30.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| LAURA NATALIA MONICA FONDA | 5% | 1,928,451 | 1,928,451 | 0 | /s/ Laura Natalia Monica Fonda | Individual |
CIK / CUSIP context first